| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/02/2000 | CA1340978C Purification, cloning and characterization of the gene for interleukin 1 |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023592A2 Minimal promoters and uses thereof |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023567A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/27/2000 | WO2000023468A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023460A1 HIGH PURITY COMPOSITION COMPRISING (7α,17α)- 17-HYDROXY- 7-METHYL- 19-NOR-17-PREGN- 5(10)-EN-20-YN-3-ONE |
| 04/27/2000 | WO2000023439A1 Vitreous form of known bradykinin antagonist |
| 04/27/2000 | WO2000023438A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | WO2000023421A1 (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023107A1 Vaccine preparations containing attenuated toxin |
| 04/27/2000 | WO2000023106A1 Bacterial extract as oral adjuvant |
| 04/27/2000 | WO2000023105A2 Adjuvant systems and vaccines |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 04/27/2000 | WO2000023088A2 Methods of administering adenoviral vectors |
| 04/27/2000 | WO2000023068A2 Fumaric acid microtablets |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000023037A1 Two chamber cartridge for atomizers |
| 04/27/2000 | WO2000007014A3 Leptin-mediated gene-induction |
| 04/27/2000 | WO2000006137A3 Glucocorticoid-selective anti-inflammatory agents |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO2000003744A3 Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 04/27/2000 | WO2000003702A8 New pharmaceutical preparation and method |
| 04/27/2000 | WO1999006544A8 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 04/27/2000 | DE19847142A1 Diagnosing borelliosis by detecting specific antibodies, using new Borellia antigens expressed preferentially during infection and also useful as immunogens in vaccines |
| 04/27/2000 | DE19845286A1 New carrier material coated with specific antibodies, used to remove tumor necrosis factor and other disease-associated compounds from blood, for treating arthritis or pyelonephritis |
| 04/27/2000 | CA2773698A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2347792A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/27/2000 | CA2347654A1 Human rna binding proteins |
| 04/27/2000 | CA2347409A1 Human proteins stam2a and stam2b and cdnas encoding these molecules |
| 04/27/2000 | CA2347369A1 Minimal promoters and uses thereof |
| 04/27/2000 | CA2347099A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2347083A1 Methods of administering adenoviral vectors |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347001A1 Vitreous form of known bradykinin antagonist |
| 04/27/2000 | CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting |
| 04/27/2000 | CA2346799A1 Delivery system for porcine somatotropin |
| 04/27/2000 | CA2346436A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | CA2346152A1 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/26/2000 | EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 04/26/2000 | EP0995756A2 Mechanism oriented inhibitors of dipeptidyl peptidase I |
| 04/26/2000 | EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995419A2 A plastic vessel containing an albumin preparation and method for producing the same |
| 04/26/2000 | EP0994947A1 Mu-1, member of the cytokine receptor family |
| 04/26/2000 | EP0994880A1 Crystalline macrolides and process for their preparation |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 04/26/2000 | EP0994856A1 Inhibitors of farnesyl protein transferase |
| 04/26/2000 | EP0994723A1 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 04/26/2000 | EP0994717A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 04/26/2000 | EP0994710A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 04/26/2000 | EP0994697A1 Rapamycin formulations for oral administration |
| 04/26/2000 | EP0802913B1 IMIDAZO [4,5-c]QUINOLINE AMINES |
| 04/26/2000 | EP0738269B1 Piperidine derivatives with paf antagonist activity |
| 04/26/2000 | EP0626853B1 Use of substituted adenine derivatives for treating multiple sclerosis |
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | EP0507872B1 The use of arginine as an immunostimulator |
| 04/26/2000 | CN1251588A Novel 3,5 and/or 6 substituted analogues of swainsonine, process for their preparation and their use as therapeutic agents |
| 04/26/2000 | CN1251582A Asymmetric synthesis of benzoxazinones via new intermediates |
| 04/26/2000 | CN1251579A Compound and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 04/26/2000 | CN1251525A Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating AIDS |
| 04/26/2000 | CN1251522A Antirheumatic agents |
| 04/26/2000 | CN1251309A Method for preparing medicinal absinthium extracted liquor and electro-moxibustion apparatus using said extracted liquor |
| 04/26/2000 | CN1251301A Biological capsule and its preparation method |
| 04/26/2000 | CN1051767C Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054470 Src family SH2 domain inhibitors |
| 04/25/2000 | US6054463 Methods for treating dermatitis using descarboethoxyloratadine |
| 04/25/2000 | US6054460 Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]pyrimidines, and process for preparing |
| 04/25/2000 | US6054430 Substantially free of species having a molecular weight of over 40 kilodaltons; trifluoroacetyl copolymer-1 treated with hbr. |
| 04/25/2000 | US6054312 Receptor-mediated gene delivery using bacteriophage vectors |
| 04/25/2000 | US6054297 Preparing humanized immunoglobulin from complimentarity and human framework region; obtaining human and mammalian variable domain sequences, detecting, replacing, and adjusting sequences, detect binding, prepare immunoglobulin |
| 04/25/2000 | US6054292 T-cell receptor protein |
| 04/25/2000 | US6054125 Purified mite allergen |
| 04/25/2000 | US6054124 A milk or a polypeptide subfraction of milk obtained from the allergen treated host, for preventing or alleviating allergic reactions |
| 04/25/2000 | US6054123 Haemophilus influenzae dimethylsulphoxide reductase enzyme |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022134A2 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 04/20/2000 | WO2000022121A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000022103A1 A modified polypeptide with reduced immune response |
| 04/20/2000 | WO2000021996A2 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | WO2000021988A2 Human ankyrin family protein |
| 04/20/2000 | WO2000021979A2 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | WO2000021959A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/20/2000 | WO2000021955A1 Quinazoline derivatives |
| 04/20/2000 | WO2000021947A1 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 04/20/2000 | WO2000021564A1 Composition and method for treating allergic diseases |
| 04/20/2000 | WO2000021559A2 Blocking factor b to treat complement-mediated immune disease |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021551A1 Isolated peptides which bind to hla-b35 molecules |
| 04/20/2000 | WO2000021547A2 Utilization of proteolytic enzymes to influence hyperactive t cells |